ADHD or not? The differential diagnoses that turn a stimulant into a poison

In recent years, adult ADHD has become one of the most sought-after diagnoses in psychiatry offices — and, at the same time, one of the most poorly investigated. The complaint is almost always the same: difficulty concentrating, frequent forgetting, the sense of always being behind, a mind that will not switch off, procrastination that has already cost a promotion and a relationship. The hurried conclusion is also familiar: “it must be ADHD.” The prescription follows almost automatically: methylphenidate or lisdexamfetamine, in increasing dose until “the effect kicks in.”

The problem is that a significant share of these cases are not ADHD. They are something else — and the stimulant prescribed under the wrong diagnosis is not neutral. It can accelerate a subclinical bipolar disorder, mask a depression, entrench an anxiety, or give the impression of improvement in the first weeks and worsen everything six months later. The patient leaves the office relieved to have “a name,” and the physician convinces himself that he has resolved the case — while the real clinical picture continues underneath, untreated, and now overlaid by a substance that alters cognition and mood. This text is about that clinical fork: why differential diagnosis matters before medication, and what a careful psychiatric evaluation looks to rule out before accepting the diagnosis.

Why the “adult ADHD” label became a magnet

There are three reasons behind the explosion of diagnoses. The first is legitimate: the condition exists, has historically been underdiagnosed, and people who spent decades blaming themselves for a specific neurobiological functioning finally find a name and a treatment. The second is cultural: the continuous attention demanded by remote work, notifications, and simultaneous cognitive load has made visible — in nearly everyone — some degree of difficulty focusing. The third is commercial: telemedicine, online symptom checklists, and a class of medications with rapid and perceptible effect create a funnel that pushes the diagnosis as the answer.

The result is a scenario in which the complaint “I can’t concentrate” arrives at the psychiatrist already translated by the patient himself as “ADHD.” And the implicit pressure — from the patient, from the system, sometimes from the physician himself — is to confirm quickly and prescribe. That is where real investigation is left behind.

What needs to be ruled out before saying it is ADHD

A well-trained psychiatrist knows that difficulty with attention is a symptom, not a diagnosis. And that there are at least five different clinical presentations that arrive at the office with that same symptom. Each of them changes the course of treatment completely.

1. Atypical depression or chronic dysthymia

Mild or moderate depressive presentations that drag on for years usually erase concentration, working memory, and motivation — exactly the picture a patient describes as “ADHD.” The clinical difference lies in the affective background: a persistent sense of emptiness, disproportionate fatigue, subtle loss of pleasure, low-grade negative rumination. The patient often does not recognize this as sadness — because it is not dramatic sadness, it is background apathy. Prescribing a stimulant here gives partial relief in the first weeks (any catecholamine lifts mood in the short term), but does not treat the depression. Six months later, the patient is worse — dependent on the stimulant, with mood even flatter during periods without medication.

2. Bipolar disorder type 2

This is the most dangerous of the differential diagnoses. Bipolar type 2 presents with clear depressive episodes and hypomanic episodes that the patient himself describes as “good phases” — high productivity, reduced sleep, creativity, energy. Because the hypomania goes unnoticed (the patient reports it as “when I was doing well”), the office complaint is the depression, or worse — the difficulty concentrating between episodes. Prescribing a stimulant here is pouring gasoline on a controlled fire. A switch to full hypomania, or even mania, is a predictable complication, and mood instability may become chronic in a way it would not have without stimulant exposure.

3. Long-standing generalized anxiety

The hypervigilance of chronic anxiety consumes cognitive resources that, phenomenologically, look exactly like attention deficit. The patient cannot focus because he is spending attention monitoring threat, reviewing yesterday’s conversations, anticipating scenarios. A stimulant here amplifies the anxiety — the patient becomes more alert, more focused, and more distressed. It is common for him to describe the effect as “I can work, but I have a tightness in my chest all day.” The way out is to treat the anxiety, not to potentiate the alarm.

4. Untreated obstructive sleep apnea

This is the most frequently ignored diagnosis. A middle-aged adult with weight gain, snoring, non-restorative sleep, and difficulty concentrating — often receives methylphenidate when what he needs is a polysomnography and CPAP. Fragmented sleep at night compromises memory consolidation and attentional sustainment the following day. No stimulant corrects this. And by postponing the sleep investigation, the patient remains exposed to the increased cardiovascular risk that apnea carries. The clinical rule is simple: in any complaint of concentration in adults, sleep must be investigated before any prescription.

5. Cognitive consequence of chronic psychic suffering

The last — and perhaps the most delicate clinically — is the case in which the difficulty attending is a consequence, not the cause, of an overloaded psychic life. Consuming relationships, unelaborated grief, chronic professional conflicts, unaddressed trauma — all of these silently consume attentional resources. The patient needs psychotherapy to elaborate what is being held under the table, not a stimulant to work through the suffering. Prescribing medication here is a functional anesthesia that postpones the necessary encounter.

What a good investigation does differently

The psychiatric interview that takes the diagnosis seriously spends time in three terrains: developmental history (the attentional pattern must have been present since childhood to characterize classic ADHD), assessment of mood and anxiety over the past two to five years, and investigation of sleep as an independent pillar. Standardized instruments help — the ASRS scale for screening, the MDQ to detect hypomanic episodes the patient does not recognize, specific questionnaires for sleep and anxiety. But no instrument replaces clinical listening: how the symptom organizes itself in the person’s life, what precedes it, what follows it, what it covers.

A good psychiatrist also knows that ADHD rarely appears in isolation. It commonly coexists with anxiety, with mild depression, with obsessive traits. Dual diagnosis changes the treatment plan — because treating only one of the vectors and ignoring the other is a recipe for failure.

When the stimulant is the right answer

This text is not anti-stimulant. When ADHD is the correct diagnosis, methylphenidate or lisdexamfetamine transform lives — they allow the person to access cognitive capacities they always had and could never sustain. The difference between that outcome and the poor one described above is one thing: whether the diagnosis was made with the care it deserves, or stamped.

A patient who receives a stimulant under the correct diagnosis reports something specific: a sense of “coming back to being me,” not of “becoming better than others.” There is no euphoria, no acceleration, no sense of being a turbocharged version. There is only the quieting of a background noise that had always been there. That is the clinical marker that the diagnosis was well made — and it is what a good psychiatric evaluation looks for before writing the prescription.

What to do if you suspect ADHD

If you identify with the picture, the first step is not to look for a psychiatrist asking for the medication. It is to look for a psychiatrist asking for an investigation. The difference is large. The evaluation will take two or three appointments, will probably request polysomnography if there is any suspicion of apnea, will apply standardized instruments for mood and anxiety, and will reconstruct with you the history of your attentional functioning since childhood. Only at the end of that path should the diagnosis be closed — either to confirm ADHD, or to name something else that was presenting in that guise.

This is the opposite of the fast flow that became popular. But it is the only one that treats what actually exists, instead of accelerating what should not be accelerated.

Dr. Leonardo Sodré is a medical psychiatrist in Brasília (CRM-DF 14,206 · RQE 14,761), with formal training and interest in psychoanalysis. This content is informational and educational, and does not replace individual clinical evaluation, diagnosis, or treatment.